Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $1.96 billion. The enterprise value is $5.82 billion.
| Market Cap | 1.96B |
| Enterprise Value | 5.82B |
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 129.58 million shares outstanding. The number of shares has increased by 1.09% in one year.
| Current Share Class | 129.58M |
| Shares Outstanding | 129.58M |
| Shares Change (YoY) | +1.09% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 67.07% |
| Float | 54.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.99 |
| PS Ratio | 0.59 |
| Forward PS | 0.57 |
| PB Ratio | 1.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.43 |
| P/OCF Ratio | 7.01 |
| PEG Ratio | 2.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.92, with an EV/FCF ratio of 27.97.
| EV / Earnings | n/a |
| EV / Sales | 1.74 |
| EV / EBITDA | 8.92 |
| EV / EBIT | 12.27 |
| EV / FCF | 27.97 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 1.16.
| Current Ratio | 1.86 |
| Quick Ratio | 1.35 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 5.43 |
| Debt / FCF | 19.42 |
| Interest Coverage | 1.70 |
Financial Efficiency
Return on equity (ROE) is 2.75% and return on invested capital (ROIC) is 5.51%.
| Return on Equity (ROE) | 2.75% |
| Return on Assets (ROA) | 3.71% |
| Return on Invested Capital (ROIC) | 5.51% |
| Return on Capital Employed (ROCE) | 6.35% |
| Weighted Average Cost of Capital (WACC) | 8.86% |
| Revenue Per Employee | $208,975 |
| Profits Per Employee | -$4,756 |
| Employee Count | 16,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 27.36 |
Taxes
In the past 12 months, SGRY has paid $16.80 million in taxes.
| Income Tax | 16.80M |
| Effective Tax Rate | 14.75% |
Stock Price Statistics
The stock price has decreased by -33.49% in the last 52 weeks. The beta is 1.95, so SGRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | -33.49% |
| 50-Day Moving Average | 13.92 |
| 200-Day Moving Average | 16.34 |
| Relative Strength Index (RSI) | 67.25 |
| Average Volume (20 Days) | 1,215,667 |
Short Selling Information
The latest short interest is 13.72 million, so 10.59% of the outstanding shares have been sold short.
| Short Interest | 13.72M |
| Short Previous Month | 14.49M |
| Short % of Shares Out | 10.59% |
| Short % of Float | 25.32% |
| Short Ratio (days to cover) | 8.04 |
Income Statement
In the last 12 months, SGRY had revenue of $3.34 billion and -$76.10 million in losses. Loss per share was -$0.60.
| Revenue | 3.34B |
| Gross Profit | 763.30M |
| Operating Income | 474.00M |
| Pretax Income | 113.90M |
| Net Income | -76.10M |
| EBITDA | 652.20M |
| EBIT | 474.00M |
| Loss Per Share | -$0.60 |
Balance Sheet
The company has $182.30 million in cash and $4.04 billion in debt, with a net cash position of -$3.86 billion or -$29.76 per share.
| Cash & Cash Equivalents | 182.30M |
| Total Debt | 4.04B |
| Net Cash | -3.86B |
| Net Cash Per Share | -$29.76 |
| Equity (Book Value) | 3.48B |
| Book Value Per Share | 13.03 |
| Working Capital | 500.80M |
Cash Flow
In the last 12 months, operating cash flow was $280.00 million and capital expenditures -$72.00 million, giving a free cash flow of $208.00 million.
| Operating Cash Flow | 280.00M |
| Capital Expenditures | -72.00M |
| Depreciation & Amortization | 178.20M |
| Net Borrowing | 70.10M |
| Free Cash Flow | 208.00M |
| FCF Per Share | $1.61 |
Margins
Gross margin is 22.83%, with operating and profit margins of 14.18% and -2.28%.
| Gross Margin | 22.83% |
| Operating Margin | 14.18% |
| Pretax Margin | 3.41% |
| Profit Margin | -2.28% |
| EBITDA Margin | 19.51% |
| EBIT Margin | 14.18% |
| FCF Margin | 6.22% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.09% |
| Shareholder Yield | -1.09% |
| Earnings Yield | -3.88% |
| FCF Yield | 10.60% |
Analyst Forecast
The average price target for SGRY is $17.95, which is 18.68% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.95 |
| Price Target Difference | 18.68% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 4.82% |
| EPS Growth Forecast (3Y) | 21.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 0.86 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.86 |
| Piotroski F-Score | 3 |